Search Results - "Lonergan, Peter"

Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis by Lonergan, Peter E, Washington Iii, Samuel L, Branagan, Linda, Gleason, Nathaniel, Pruthi, Raj S, Carroll, Peter R, Odisho, Anobel Y

“…The emergence of the coronavirus disease (COVID-19) pandemic in March 2020 created unprecedented challenges in the provision of scheduled ambulatory cancer…”
Get full text

Androgen receptor signaling in prostate cancer development and progression by Lonergan, Peter E, Tindall, Donald J

“…The androgen receptor (AR) signaling axis plays a critical role in the development, function and homeostasis of the prostate. The classical action of AR is to…”
Get full text

Editorial Comment on “Clinical Decision Support for Surgery: A Mixed Methods Study on Design and Implementation Perspectives From Urologists” by Khan, Jody S.A., Lonergan, Peter E.

Get full text

The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer by Maggi, Martina, Cowan, Janet E., Fasulo, Vittorio, Washington, Samuel L., Lonergan, Peter E., Sciarra, Alessandro, Nguyen, Hao G., Carroll, Peter R.

“…PURPOSEWe assessd the long-term outcomes from a large prospective cohort of men diagnosed with prostate cancer managed with active surveillance and determined…”
Get full text

Clinical Utility of 4Kscore ® , ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer by de la Calle, Claire M, Fasulo, Vittorio, Cowan, Janet E, Lonergan, Peter E, Maggi, Martina, Gadzinski, Adam J, Yeung, Reuben Au, Saita, Alberto, Cooperberg, Matthew R, Shinohara, Katsuto, Carroll, Peter R, Nguyen, Hao G

“…We aimed to evaluate 4Kscore and ExosomeDx™ with multiparametric magnetic resonance imaging in the detection of high grade prostate cancer and number of…”
Get full text

The endoplasmic reticulum stress response in prostate cancer by de la Calle, Claire M., Shee, Kevin, Yang, Heiko, Lonergan, Peter E., Nguyen, Hao G.

“…In order to proliferate in unfavourable conditions, cancer cells can take advantage of the naturally occurring endoplasmic reticulum-associated unfolded…”
Get full text

Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443–51 by Chu, Carissa E., Lonergan, Peter E., Carroll, Peter R.

Get full text

Explainable ML models for a deeper insight on treatment decision for localized prostate cancer by Han, Jang Hee, Lee, Sungyup, Lee, Byounghwa, Baek, Ock-kee, Washington, Samuel L., Herlemann, Annika, Lonergan, Peter E., Carroll, Peter R., Jeong, Chang Wook, Cooperberg, Matthew R.

“…Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the…”
Get full text

Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer by Lonergan, Peter E, Washington, 3rd, Samuel L, Cowan, Janet E, Zhao, Shoujun, Broering, Jeanette M, Cooperberg, Matthew R, Carroll, Peter R

“…The association between androgen deprivation therapy (ADT) and dementia in men with prostate cancer remains inconclusive. We assessed the association between…”
Get full text

The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer by Chappidi, Meera R, Bell, Alexander, Cowan, Janet E, Greenberg, Scott A, Lonergan, Peter E, Washington, 3rd, Samuel L, Nguyen, Hao G, Shinohara, Katsuto, Cooperberg, Matthew R, Carroll, Peter R

“…For men with clinically localized prostate cancer outcomes of continuing active surveillance (AS) after biopsy progression are not well understood. We aim to…”
Get full text

Objective scoring of an electronic surgical logbook: Analysis of impact and observations within a surgical training body by Harrington, Cuan M., Kavanagh, Dara O., Ryan, Donncha, Dicker, Patrick, Lonergan, Peter E., Traynor, Oscar, Tierney, Sean

“…Historically, evaluating operative-volumes has proven difficult due to mass-variability in operative-complexities and participation. This study aimed to…”
Get full text

Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer by Chu, Carissa E., Lonergan, Peter E, Washington, Samuel L., Cowan, Janet E, Shinohara, Katsuto, Westphalen, Antonio C., Carroll, Peter R., Cooperberg, Matthew R

“…Multiparametric magnetic resonance imaging (mpMRI) has improved the detection of clinically significant prostate cancer. It remains unclear, however, whether…”
Get full text

Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer by Lonergan, Peter E, Washington, 3rd, Samuel L, Cowan, Janet E, Zhao, Shoujun, Nguyen, Hao G, Shinohara, Katsuto, Cooperberg, Matthew R, Carroll, Peter R

“…Few validated clinical tools currently exist to standardize the frequency of biopsies for men on active surveillance for low risk prostate cancer. We…”
Get full text

A Cross-Sectional Analysis of Barriers Associated With Non-Attendance at a Urology Telehealth Clinic in a Safety-Net Hospital by Bell, Alexander, Lonergan, Peter E., Escobar, Domenique, Fakunle, Mary, Chu, Carissa E., Berdy, Sara, Palmer, Nynikka R., Breyer, Benjamin N., Washington, Samuel L.

“…To analyze the factors associated with non-attendance at a urology telehealth clinic in a large urban safety-net hospital after institutional-mandated…”
Get full text

The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells by Lu, Ji, Lonergan, Peter E, Nacusi, Lucas P, Wang, Liguo, Schmidt, Lucy J, Sun, Zhifu, Van der Steen, Travis, Boorjian, Stephen A, Kosari, Farhad, Vasmatzis, George, Klee, George G, Balk, Steven P, Huang, Haojie, Wang, Chunxi, Tindall, Donald J

“…Purpose Spliced variant forms of androgen receptor were recently identified in castration resistant prostate cancer cell lines and clinical samples. We…”
Get full text

Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US by Washington, 3rd, Samuel L, Jeong, Chang Wook, Lonergan, Peter E, Herlemann, Annika, Gomez, Scarlett L, Carroll, Peter R, Cooperberg, Matthew R

“…Active surveillance (AS) is now recognized as the preferred management option for most low-risk prostate cancers to minimize risks of overtreatment. Despite…”
Get full text

The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer by Lonergan, Peter E., Baskin, Avi, Greenberg, Scott A., Mohamad, Osama, Washington, Samuel L., Zhao, Shoujun, Cowan, Janet E., Broering, Jeanette M., Nguyen, Hao G., Cooperberg, Matthew R., Breyer, Benjamin N., Carroll, Peter R.

“…To assess the long-term incidence of treatment-related toxicities and quality of life (QOL) outcomes associated with toxicity after external beam radiotherapy…”
Get full text

Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort by Lonergan, Peter E., Cowan, Janet E., Washington, Samuel L., Greenberg, Scott A., Nguyen, Hao G., Carroll, Peter R.

“…Background A detectable prostate‐specific antigen (PSA) following radical prostatectomy (RP) is an unfavorable prognostic factor. However, not all men with a…”
Get full text

Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen by Greenberg, Scott A., Washington, Samuel L., Lonergan, Peter E., Cowan, Janet E., Baskin, Avi S., Nguyen, Hao G., Odisho, Anobel Y., Simko, Jeffry P., Carroll, Peter R.

“…PURPOSETo determine if benign glandular tissue at the surgical margin (BGM) is associated with detectable prostate specific antigen (PSA) and/or biochemical…”
Get full text

Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database by de la Calle, Claire M., Washington, Samuel L., Lonergan, Peter E., Meng, Maxwell V., Porten, Sima P.

“…Purpose To evaluate the clinical, pathological, and survival outcomes of bladder cancer in patients aged 18–40 years. Methods We identified 362,091 bladder…”
Get full text